Eurazeo SE

Equities

RF

FR0000121121

Investment Management & Fund Operators

Real-time Euronext Paris Other stock markets 09:30:03 2024-04-25 am EDT			5-day change	1st Jan Change
82.95 ^EUR	-1.54%		+1.90%	+15.45%

Apr. 24	Tikehau Capital: 13% increase in assets under management in Q1	CF
Apr. 22	Eurazeo: agreement to invest in Eres Group	CF

Eurazeo : Déclaration hebdomadaire d'opérations effectuées du 21 au 25 novembre 2022

November 28, 2022 at 12:40 pm EST

Déclaration hebdomadaire d'opérations effectuées du 21 au 25 novembre 2022

28 Nov 2022 18:30 CET

Issuer

EURAZEO

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1121849_DeclarationAMF21au25novembre2022.pdf

Source

EURAZEO

Provider

Les Echos

Company Name

EURAZEO SE

ISIN

FR0000121121

Symbol

Market

Euronext

Attachments

Original Link
Original Document
Permalink

Disclaimer

Eurazeo SA published this content on 28 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 November 2022 17:39:09 UTC.

Latest news about Eurazeo SE

Tikehau Capital: 13% increase in assets under management in Q1	Apr. 24	CF
Eurazeo: agreement to invest in Eres Group	Apr. 22	CF
Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024.	Apr. 21	CI
Arielle Zuckerberg firm invests in French space tech company Dark	Apr. 15	RE
SAS DARK announced that it has received $11 million in funding from Eurazeo SE, Otium Capital, Kima Ventures SAS, Long Journey Ventures, Frst Capital	Apr. 15	CI
SAS DARK announced that it has received $6 million in funding from Eurazeo SE, Long Journey Ventures	Apr. 14	CI
Carl Zeiss Meditec expands ophthalmology portfolio through acquisition	Apr. 04	DP
Eurazeo Completes Sale of Medical Device Company to Carl Zeiss Meditec	Apr. 04	MT
Eurazeo: finalizes sale of DORC	Apr. 03	CF
Carl Zeiss Meditec AG completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).	Apr. 02	CI
Eurazeo SE Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Qoala announced that it has received $47 million in funding from a group of investors	Mar. 26	CI
EURAZEO : Berenberg raises target, maintains buy recommendation	Mar. 18	CF
Eurazeo: the stock outperforms, an analyst raises his target	Mar. 18	CF
Eurazeo: agreement for the sale of Peters Surgical	Mar. 13	CF
Advanced Medical Solutions Group to Buy Peters Surgical	Mar. 13	MT
PPRO Financial Ltd announced that it has received $92.8 million in funding from a group of investors	Mar. 12	CI
Advanced Medical Solutions Group plc entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for ?140 million.	Mar. 12	CI
EURAZEO : Eurazeo stays the course and rewards its shareholders	Mar. 07
Eurazeo SE Proposes Ordinary Dividend for the Year 2023	Mar. 07	CI
Transcript : Eurazeo SE, 2023 Earnings Call, Mar 07, 2024	Mar. 07
Eurazeo: annual RNPG breakeven excluding exceptional items	Mar. 07	CF
Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for ?200 million worth of its shares.	Mar. 07	CI
Tranche Update on Eurazeo SE (ENXTPA:RF)'s Equity Buyback Plan announced on March 8, 2023.	Mar. 06	CI
Eurazeo: Adrien Pinelli strengthens Middle East team	Mar. 04	CF

Chart Eurazeo SE

Duration

Period

More charts

Company Profile

Eurazeo SE is a leading European investment group with diversified assets under management of EUR 35 billion, including EUR 24.2 billion on behalf of institutional and individual clients through its private equity, private debt, real estate and infrastructure strategies. The group supports over 600 mid-market companies, leveraging the commitment of its 400 employees, its sector expertise, its privileged access to global markets via 12 offices in Europe, Asia and the United States, and its responsible approach to value creation based on growth. Eurazeo's institutional and family shareholding and its solid financial structure ensure its long-term viability. Eurazeo SE has offices in Paris, New York, London, Frankfurt, Berlin, Milan, Madrid, Luxembourg, Shanghai, Seoul, Singapore and Saõ Paulo.

Sector

Investment Management & Fund Operators

Calendar

2024-05-07 - Annual General Meeting

Related indices

STOXX EUROPE 600 (EUR) , CAC Mid 60

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

EURAZEO : Eurazeo stays the course and rewards its shareholders

March 07, 2024 at 09:30 am EST

More Strategies

Ratings for Eurazeo SE

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

84.25 EUR

Average target price

93.5 EUR

Spread / Average Target

+10.98%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
EURAZEO SE	+15.45%	6.63B
BLACKROCK, INC.	-6.04%	113B
UBS GROUP AG	-4.29%	87.84B
APOLLO GLOBAL MANAGEMENT, INC.	+20.96%	64.04B
BROOKFIELD CORPORATION	+4.46%	61.27B
BANK OF NEW YORK MELLON CORPORATION (THE)	+11.34%	43.34B
AMERIPRISE FINANCIAL, INC.	+8.70%	41.12B
3I GROUP PLC	+17.19%	34.17B
T. ROWE PRICE GROUP INC.	+3.13%	24.84B
STATE STREET CORPORATION	-4.09%	22.4B

Other Investment Management & Fund Operators